UK markets open in 4 hours 22 minutes

Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
44.03+0.26 (+0.59%)
At close: 04:00PM EDT
42.50 -1.53 (-3.47%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
373,281
373,281
437,072
181,486
98,460
Selling general and administrative
62,770
62,770
130,860
37,414
16,046
Total operating expenses
436,051
436,051
567,932
218,900
114,506
Operating income or loss
-436,051
-436,051
-567,932
-218,900
-114,506
Total other income/expenses net
26,500
26,500
-1,909
6,470
-4,162
Income before tax
-409,551
-409,551
-569,841
-212,430
-118,668
Income tax expense
-1,383
-1,383
438
1,366
0
Income from continuing operations
-408,168
-408,168
-570,279
-213,796
-118,668
Net income
-408,168
-408,168
-570,279
-213,796
-118,668
Net income available to common shareholders
-408,168
-408,168
-570,279
-213,796
-118,668
Basic EPS
-7.23
-
-12.75
-5.97
-3.31
Diluted EPS
-7.23
-
-12.75
-5.97
-3.31
Basic average shares
66,403
-
44,741
35,823
35,823
Diluted average shares
66,403
-
44,741
35,823
35,823